Results 151 to 160 of about 490,554 (298)
The effects of surface active agents on the behaviour of selected crustaceans [PDF]
, 1977 The effect of surface active agents on behaviour has been examined. The study has investigated two areas in which these chemicals are thought to cause debilitating effects, namely in the animal's general activity,and in its ability to perceive its ...
Lyes, Martin Christopher
core
A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai +5 more
wiley +1 more source
Modifications de tensions superficielles et interfaciales permises par l’emploi des agents de surface [PDF]
, 1963 Surface and interfacial tension changes brought about by the application of surface active agents. Adsorption in interfaces, formation and properties of monomolecular films. Variation of superficial and interfacial tension as a function of concentration.
Roussos, M.
core
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
INTERACTION OF DNA WITH THE FOLDED AND UNFOLDED HISTONE HI IN THE PRESENCE OF SURFACE ACTIVE AGENTS [PDF]
Journal of Sciences, Islamic Republic of Iran, 1996 Interaction between DNA and histone H, was investigated in the presence and absence of sodium-n-dodecyl sulphate (SDS) and dodecyl trimethylammonium bromide (DTAB) at temperatures of 27 and 37?C, in 2.5 mM phosphate buffer, pH 6.4 by UV spectrophotometry,
doaj
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.Markers of neutrophil activation are increased in plasma during ALS, and markers of NET formation associate with ALS survival. ABSTRACT Objectives Peripheral neutrophil levels in amyotrophic lateral sclerosis (ALS) inversely correlate with survival, suggesting a role for neutrophils in disease progression.
Lillia A. Baird +9 more
wiley +1 more source
GLYCOSIDIC PERFLUOROALIPHATIC SURFCE-ACTIVE AGENTS, THEIR PREPARATION AND USE [PDF]
, 1997 The present invention is concerned with the synthesis of new carbamates derived from monosaccharides or disaccharides and their precursors. These compounds may be used as surface-active agents or co-surface-active agents of yolk phospholipids or Pluronic
LOWE K. +9 more
core
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source